Related Experiment Video

Updated: Jul 20, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

Endothelial dysfunction and its role in diabetic vascular disease

Martin M Hartge1, Ulrich Kintscher, Thomas Unger

  • 1Center for Cardiovascular Research, Institute for Pharmacology, Charité Berlin, Hessische Strasse 3-4, 10115 Berlin, Germany.

Endocrinology and Metabolism Clinics of North America
|September 9, 2006
PubMed

Insights

Endothelial dysfunction, characterized by inflammation and reduced vasodilation, increases cardiovascular risk. Targeting this dysfunction is crucial for treating cardiovascular disease in type 2 diabetes patients.

Area of Science:

  • Cardiovascular Medicine
  • Endothelial Biology
  • Diabetology

Background:

  • Normal endothelial function is critical for vascular health.
  • Pathological shifts in endothelial function underpin various diseases.
  • Endothelial dysfunction involves inflammation, impaired vasodilation, and prothrombotic states.

Purpose of the Study:

  • To highlight the role of endothelial dysfunction in cardiovascular disease.
  • To emphasize the exacerbated endothelial dysfunction in type 2 diabetes.
  • To propose endothelial dysfunction as a primary therapeutic target in diabetic cardiovascular disease.

Main Methods:

  • Review of existing literature on endothelial function and dysfunction.
  • Analysis of the link between endothelial dysfunction and cardiovascular morbidity/mortality.
  • Examination of the specific impact of type 2 diabetes on endothelial health.

Main Results:

  • Endothelial dysfunction is a key factor in cardiovascular morbidity and mortality.
  • Type 2 diabetes significantly enhances endothelial dysfunction.
  • This dysfunction is a major contributor to the elevated cardiovascular risk in diabetic patients.

Conclusions:

  • Endothelial dysfunction is a central pathophysiological mechanism in diabetic cardiovascular disease.
  • Therapeutic strategies for diabetic cardiovascular disease should prioritize targeting the endothelium.
  • Addressing endothelial dysfunction offers a promising avenue for reducing cardiovascular risk in diabetes.

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.